Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 14, 2005
Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndromeJ C H van der Hilst, J P H Drenth, E J Bodar, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistatE J Smolders, E P H Colbers, C T M M de Kanter, et al.
International Journal of Antimicrobial Agents|February 11, 2017
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?E J Smolders, S Pape, C T M M de Kanter, et al.
Best Practice & Research. Clinical Gastroenterology|February 4, 2014
Laparoscopy in cholecysto-choledocholithiasisA H van Dijk, M Lamberts, C J H M van Laarhoven, et al.
Clinical Pharmacokinetics|June 19, 2016
Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive MedicationsE J Smolders, C T M M de Kanter, R J de Knegt, et al.
Journal of Leukocyte Biology|February 21, 2008
Lovastatin inhibits formation of AA amyloidJ C H van der Hilst, B Kluve-Beckerman, E J Bodar, et al.
Neurology|March 24, 2004
Mevalonate kinase deficiency: Evidence for a phenotypic continuumA Simon, H P H Kremer, R A Wevers, et al.
Pageof 9